Generac executive sells 603 shares in planned trade

A Generac Holdings executive exercised options for 213 shares and sold 603 shares of GNRC stock on September 17, 2026 under a Rule 10b5-1 plan.

Rhea-AI Filing Summary

GENERAC HOLDINGS INC. (GNRC) reported that Kyle Andrew Raabe, President, Home Power Gen., exercised stock options and sold shares on September 17, 2026. He exercised options for 213 shares of common stock at an exercise price of $102.415 per share, then sold a total of 603 shares of common stock at $229.50 per share in open-market or private transactions. The exercised options and related common stock transactions were carried out pursuant to a Rule 10b5-1(c) trading plan adopted on May 5, 2026. Following the derivative transaction, 637 stock options remained outstanding from the referenced grant.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Raabe Kyle Andrew

Role President, Home Power Gen.

Sold 603 shs ($138K)

Approx. gross sale proceeds $138K

Approx. exercise cost $22K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F2	213	$0.00	$0.00
Sale	Common Stock F1	390	$229.50	$90K
Exercise	Common Stock F1	213	$102.415	$22K
Sale	Common Stock F1	213	$229.50	$49K

Holdings After Transaction: Stock Option (Right to Buy) — 637 contracts (Direct); Common Stock — 10,356 shares (Direct)

Footnotes (2)

1. F1. Adoption date of referenced 10b5-1(c) plan is: 05-05-2026
2. F2. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

Key Figures

Shares sold: 603 shares Shares sold block: 390 shares Shares from option exercise: 213 shares +4 more

7 metrics

Shares sold 603 shares Total GNRC common shares sold on September 17, 2026

Shares sold block 390 shares Part of the total shares sold on September 17, 2026

Shares from option exercise 213 shares Common shares acquired via option exercise on September 17, 2026

Sale price $229.50 per share Price for both reported GNRC common stock sales on September 17, 2026

Option exercise price $102.415 per share Exercise price for the 213 GNRC shares acquired via stock options

Options remaining 637 options Stock options remaining from the referenced grant after the exercise

10b5-1 plan adoption date May 5, 2026 Adoption date of the Rule 10b5-1(c) trading plan covering the transactions

Key Terms

Stock Option (Right to Buy), Rule 10b5-1(c) plan, graded vesting schedule, Exercise or conversion of derivative security, +1 more

5 terms

Stock Option (Right to Buy) financial

"The security title for the derivative transaction is Stock Option (Right to Buy)"

Rule 10b5-1(c) plan regulatory

"Adoption date of referenced 10b5-1(c) plan is: 05-05-2026"

graded vesting schedule financial

"Grant has a graded vesting schedule. Date exercisable will vary"

Exercise or conversion of derivative security financial

"Transaction code M is described as Exercise or conversion of derivative security"

open market or private transaction financial

"Transaction code S is described as Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GNRC report for Kyle Andrew Raabe?

GNRC reported that Kyle Andrew Raabe exercised options for 213 shares of common stock at an exercise price of $102.415 per share and sold a total of 603 shares at $229.50 per share on September 17, 2026.

How many GNRC shares did the Generac executive sell in this Form 4?

Kyle Andrew Raabe sold a total of 603 shares of Generac common stock, consisting of 390 shares and an additional 213 shares sold at a price of $229.50 per share on September 17, 2026.

At what prices were the GNRC option exercise and share sales reported?

The options were exercised at an exercise price of $102.415 per share, and the sales of Generac common stock were executed at $229.50 per share on September 17, 2026.

Were the GNRC insider transactions made under a Rule 10b5-1 plan?

Yes. The Form 4 states that the relevant option exercise and common stock transactions for GNRC were made pursuant to a Rule 10b5-1(c) trading plan with an adoption date of May 5, 2026.

How many GNRC stock options remain after the reported transactions?

After the reported derivative transaction, 637 stock options related to the referenced grant remained outstanding for Kyle Andrew Raabe, according to the Form 4 data.

What role does Kyle Andrew Raabe hold at GNRC in this Form 4?

In this Form 4 for GNRC, Kyle Andrew Raabe is identified as an officer with the title President, Home Power Gen., and the reported transactions relate to his equity in Generac Holdings Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/18/2026 - 04:09 PM Accepted by SEC EDGAR 09/18/2026 - 04:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Raabe Kyle Andrew

(Last) (First) (Middle)

S45 W29290 HWY.59

C/O GENERAC HOLDINGS INC.

(Street)

WAUKESHA WISCONSIN 53189

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENERAC HOLDINGS INC. [ GNRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Home Power Gen.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2026		S(1)		390	D	$229.5	10,356	D
Common Stock	09/17/2026		M(1)		213	A	$102.415	10,569	D
Common Stock	09/17/2026		S(1)		213	D	$229.5	10,356	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$102.415	09/17/2026		M			213	(2)	03/01/2030	Common Stock	213	$0	637	D

Explanation of Responses:

1. Adoption date of referenced 10b5-1(c) plan is: 05-05-2026

2. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

	/s/ Raj Kanuru, Attorney in Fact	09/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)